(Q42660263)

4 November 2017

Dose linearity testing of intravenous cefpirome (HR 810), a novel cephalosporin derivate (English)

1 reference

4 November 2017

L Maass

1

1 reference

4 November 2017

V Malerczyk

2

1 reference

4 November 2017

M Verho

3

1 reference

4 November 2017

P Hajdú

4

1 reference

4 November 2017

K Seeger

5

1 reference

4 November 2017

N Klesel

6

1 reference

4 November 2017

1 May 1987

1 reference

4 November 2017

1 reference

4 November 2017

15

1 reference

4 November 2017

202-206

1 reference

4 November 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01646051

4 November 2017

0 references

cites work

Pharmacokinetics of cefamandole using a HPLC assay

1 reference

12 December 2020

HR 810, a new parenteral cephalosporin with a broad antibacterial spectrum

1 reference

12 December 2020

The antibacterial activity in vitro and β-lactamase stability of the new cephalosporin HR 810 in comparison with five other cephalosporins and two aminoglycosides

1 reference

12 December 2020

Comparative in vitro activity of cefpirome and other antimicrobial agents against isolates from cancer patients

1 reference

12 December 2020

Pharmacokinetics and Clinical Use of Cephalosporin Antibiotics

1 reference

12 December 2020

In vitro activity of cefpirome (HR810) against antibiotic-resistant gram-positive and gram-negative bacteria including organisms with inducible resistance.

1 reference

12 December 2020

The efficient use of NONLIN for unbalanced multiple dose data

1 reference

12 December 2020

Chemotherapeutic properties of the new cephalosporin antibiotic HR810 in laboratory animals

1 reference

12 December 2020

Ceftizoxime kinetics and renal handling

1 reference

12 December 2020

A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01646051

1 reference

4 November 2017

1 reference